Michigan Medicine University of Michigan is a clinical research site located in Ann Arbor, Michigan, United States 48109.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Michigan Medicine University of Michigan has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis, GSD1.
Sponsors: Blueprint Medicines Corporation, Ultragenyx Pharmaceutical Inc, HighTide Biopharma Pty Ltd.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Michigan Medicine University of Michigan has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Michigan Medicine University of Michigan has 5 clinical trials on record, with 1 currently active. Their work covers Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis, GSD1.
Yes — Michigan Medicine University of Michigan holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.